This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.

Video

(1 of 3) The NHS of the Future: Diabetes General Practice Case Study

Length: 3:33

On 22nd April, Scott McKenzie Consultancy led the Diabetes Commercial Webcast, ‘The NHS of the Future - why smart resourcing and system redesign is key.’ These 3 video case studies are structured around the NHS Agenda of ‘Workforce, Workload and Innovation.’

Interested in finding out about future MSD online events?

Interested in understanding how Steglatro® (ertugliflozin) can support your affordability challenges?

Supporting documentation

STEGLATRO® (ertugliflozin) 5 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

STEGLATRO® (ertugliflozin) 15 mg
Prescribing Information | Summary of Product Characteristics | Patient Information Leaflet

GB-STE-00353 | Date of Preparation: June 2020